Skip to content
Ships from Provo, Utah · We ship to CanadaAll Prices are in US DollarsFor Research Use Only. Not for Human Consumption.

HBSP and Rabbit Atherosclerosis: Plaque Measurements Are Not Clinical Events

This study combined cell experiments with a rabbit model of inherited hyperlipidemia. Its central in-vivo question concerned coronary lesion development, not prevention of heart attacks in people. Primary report

What the study measured

Sixteen WHHLMI rabbits began HBSP or scrambled-peptide treatment; one control animal was excluded for poor feeding. After 32 weeks, treated animals had less coronary cross-sectional stenosis. The paper also reported endothelial-cell and inflammatory measurements. Its methods identify HBSP as QEQLERALNSS, making exact molecular identity important when comparing it with other helix-B preparations. Primary report

Our appraisal: keep the experimental unit visible

A coronary artery can provide many sections, but those sections are not independent animals. A reader should check whether the analysis respects nesting within rabbits. Otherwise a large number of images could create a misleading impression of biological replication.

The scrambled-peptide comparator is useful because it asks more than whether an injection differs from no intervention. It does not eliminate every alternative explanation, and it does not validate another preparation merely because that preparation has a related name.

Plaque area or narrowing is an anatomical endpoint. A claim about mortality, infarction, or symptom prevention requires those outcomes to be studied directly. Mechanistic cell assays can strengthen a biological rationale without supplying the missing clinical evidence.

Finally, exclusions should remain visible. A predeclared exclusion rule and a post hoc decision have different implications, so the timing and rationale deserve review. This report supports further investigation of lesion biology in its model. It does not establish a human cardiovascular benefit or certify a commercial product's composition, effectiveness, or safety.

Frequently asked questions

Was the in-vivo experiment in humans?

No; it used WHHLMI rabbits.

What was the comparator?

A scrambled peptide.

Were all starting animals analyzed?

One control rabbit was excluded.

Is every artery section an independent replicate?

No; sections from the same animal are related observations.

Does less stenosis prove fewer human heart attacks?

No.

Why preserve the reported sequence?

To prevent unsupported equivalence between related peptides.

What is the appropriate conclusion?

A model-specific anatomical and mechanistic finding requiring further validation.

Information you can check.

Lab reports, store policies, and support — all in one place.

Card options
Visa Mastercard
Available payment options are shown at checkout.
HTTPS connection

For research use only.
Not for human consumption.